Psychiatry Generic Medicines
key details
| Value | £14,920,581 |
|---|---|
| Status | complete |
| Category (CPV) | 33600000 |
| Region | Scotland |
| Deadline | 21 Jun 2021 |
| Procedure | open |
| OCID | ocds-h6vhtk-02b2fa |
Awards (35)
This procurement was awarded to 34 suppliers. Values shown are per-award; the notice total is £14,920,581.
| Supplier | Value | Date | Status |
|---|---|---|---|
| Accord-UK Ltd shared | · | · | active |
| Aspire Pharma Ltd shared | · | · | active |
| Aventis Pharma Ltd Trading As Sanofi shared | · | · | active |
| Colonis Pharma Ltd shared | · | · | active |
| Consilient Health Ltd shared | · | · | active |
| CST Pharma Ltd shared | · | · | active |
| Desitin Pharma Ltd shared | · | · | active |
| Dr Reddy's Laboratories (UK) Ltd shared | · | · | active |
| DRUGSRUS LTD shared | · | · | active |
| Focus Pharmaceuticals Ltd shared | · | · | active |
| GlaxoSmithKline shared | · | · | active |
| Glenmark Pharmaceuticals Europe Ltd shared | · | · | active |
| hameln pharma ltd shared | · | · | active |
| Intrapharm Laboratories Ltd shared | · | · | active |
| Janssen-Cilag Ltd shared | · | · | active |
| Kent Pharmaceuticals Ltd shared | · | · | active |
| Martindale Pharma shared | · | · | active |
| Medreich PLC shared | · | · | active |
| Mercury Pharma Group shared | · | · | active |
| Morningside Pharmaceuticals Limited shared | · | · | active |
| Mylan shared | · | · | active |
| Panpharma UK Ltd shared | · | · | active |
| Pfizer Ltd shared | · | · | active |
| Reig Jofre UK Ltd shared | · | · | active |
| Roche Products Ltd shared | · | · | active |
| Rosemont Pharmaceuticals Ltd shared | · | · | active |
| Sandoz Ltd shared | · | · | active |
| Selective Supplies Ltd shared | · | · | active |
| Syri Limited T/A Thame Laboratories shared | · | · | active |
| Teva UK Limited shared | · | · | active |
| Thornton & Ross Ltd shared | · | · | active |
| Upjohn UK Limited shared | · | · | active |
| Wockhardt UK Limited shared | · | · | active |
| Zentiva Pharma UK Ltd shared | · | · | active |
| not named shared | · | · | unsuccessful |
description
This Framework Agreement is for the supply of Psychiatry Generic Medicines to health boards across NHS Scotland. The Goods have been split into seven (7) categories, each of which is identified as a "Lot". Full details of each Lot is contained in section II.2 of this notice.
notice history
2 notices published against this procurement.
| Published | Type | Regime | Notice |
|---|---|---|---|
| 20 May 2021 | Contract notice (F02) | Earlier regulations | 011145-2021 |
| 3 Sept 2021 | Contract award notice (F03) | Earlier regulations | 021821-2021 |
more from The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS")
- Islet Cell Processing Systems · 22 Jul 2026
- C002181 Building on the NES Education and Career Pathway for Adult Integrated Community Nursing in Scotland. · 17 Jul 2026
- Insulin Infusion Pumps, Continuous Glucose Monitoring Systems and Associated Consumables · £140,000,000 · 9 Jul 2026
- Cleaning Wipe Products Surface and Patient · £18,800,000 · 12 Jun 2026
- Cath Labs and Cardiology Stents · £40,800,000 · 12 Jun 2026
- NP57026 Disposable Medical Pulp and Associated Products · £11,406,834 · 11 Jun 2026
- Orthotic Consumables · £1,600,000 · 26 May 2026
- NP36126 Antibiotic & Genito Urinary Medicines · £88,941,093 · 25 May 2026
all contracts from this buyer →
similar contracts awarded
Other awarded contracts in the same category. Useful for seeing who normally wins this kind of work, and at what value.
- Radiopharmaceutical Products - Poltech · The Christie NHS Foundation Trust · £39,000
- NHS Branded Medicines - Tranche B - London & South of England - 1 September 2026 · NHS England · £592,363,416
- NHS National Generics Pharmaceuticals - Supply Chain Resilience · NHS England · £52,447,296
- Generic, Branded Generic & Proprietary Medicinal Products - Group 18 · Regional Business Services Organisation, Procurement and Logistics Service · £1,800,000,000
- Generic Drugs – Injections/Infusions 2 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £6,535,850
- NP90726m Vedolizumab (Entyvio®) · The Common Services Agency (more commonly known as Public Services Delivery Scotland) (PSD Scotland)
- Transitional Drugs 7 · NHS Wales Shared Services Partnership-Procurement Services (hosted by Velindre University NHS Trust) · £53,566,932
- Combined Needles and Syringes Lot 1 · Secretary of State for Health and Social Care acting as part of the Crown through UK Health Security Agency · £15,264,000
source
Published on Find a Tender. Contact details for named individuals are not reproduced on this site.